Proteomic analysis of pleural effusion from lung adenocarcinoma patients by shotgun strategy

Clinical and Translational Oncology

Volumn 16, Issue 2, 2014, Pages 153-157

  Sheng, Shu Hong ^a   Zhu, Hui Li ^a  

^a HUADONG HOSPITAL AFFILIATED TO FUDAN UNIVERSITY   (China)

Author keywords

Biomarker; Malignant pleural effusion; Proteomic; Shotgun

Indexed keywords

ADENOCARCINOMA; AGED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PLEURAL EFFUSION, MALIGNANT; PROTEOME; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 84893742682     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-013-1054-9     Document Type: Article

References (30)

1. Rodriguez-Panadero F, Borderas Naranjo F, Lopez Mejias J. Pleural metastatic tumours and effusions. Frequency and pathogenic mechanisms in a post-mortem series. Eur Respir J. 1989;2(4):366-9.
2. Medford AR, Maskell N. Pleural effusion. Postgrad Med J. 2005;81(961):702-10. doi: 10.1136/pgmj.2005.035352.
3. Chernow B, Sahn SA. Carcinomatous involvement of the pleura: an analysis of 96 patients. Am J Med. 1977;63(5):695-702.
4. Tyan YC, Wu HY, Su WC, Chen PW, Liao PC. Proteomic analysis of human pleural effusion. Proteomics. 2005;5(4):1062-74. doi: 10.1002/pmic.200401041.
5. Adkins JN, Varnum SM, Auberry KJ, Moore RJ, Angell NH, Smith RD, et al. Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol Cell Proteomics. 2002;1(12):947-55.
6. Chignard N, Beretta L. Proteomics for hepatocellular carcinoma marker discovery. Gastroenterology. 2004;127(5 Suppl 1):S120-5.
7. Davidson B, Espina V, Steinberg SM, Florenes VA, Liotta LA, Kristensen GB, et al. Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling. Clin Cancer Res. 2006;12(3 Pt 1):791-9. doi: 10.1158/1078-0432.CCR-05-2516.
8. Bloomston M, Zhou JX, Rosemurgy AS, Frankel W, Muro-Cacho CA, Yeatman TJ. Fibrinogen gamma overexpression in pancreatic cancer identified by large-scale proteomic analysis of serum samples. Cancer Res. 2006;66(5):2592-9. doi: 10.1158/0008-5472.CAN-05-3659.
9. Tyan YC, Wu HY, Lai WW, Su WC, Liao PC. Proteomic profiling of human pleural effusion using two-dimensional nano liquid chromatography tandem mass spectrometry. J Proteome Res. 2005;4(4):1274-86. doi: 10.1021/pr049746c.
10. Kersey PJ, Duarte J, Williams A, Karavidopoulou Y, Birney E, Apweiler R. The International Protein Index: an integrated database for proteomics experiments. Proteomics. 2004;4(7):1985-8. doi: 10.1002/pmic.200300721.
11. Wu W, Tang X, Hu W, Lotan R, Hong WK, Mao L. Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry. Clin Exp Metastasis. 2002;19(4):319-26.
12. Danielsen EM, van Deurs B, Hansen GH. "Nonclassical" secretion of annexin A2 to the lumenal side of the enterocyte brush border membrane. Biochemistry. 2003;42(49):14670-6. doi: 10.1021/bi0355239.
13. Farber SA, De Rose RA, Olson ES, Halpern ME. The zebrafish annexin gene family. Genome Res. 2003;13(6A):1082-96. doi: 10.1101/gr.47960313/6a/1082
14. MacLeod TJ, Kwon M, Filipenko NR, Waisman DM. Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin. J Biol Chem. 2003;278(28):25577-84. doi: 10.1074/jbc.M301017200M301017200.
15. Xiong XD, Xu LY, Shen ZY, Cai WJ, Luo JM, Han YL, et al. Identification of differentially expressed proteins between human esophageal immortalized and carcinomatous cell lines by two-dimensional electrophoresis and MALDI-TOF-mass spectrometry. World J Gastroenterol. 2002;8(5):777-81.
16. Li Cui XZ, Zhang XP, Chen ZC WX, Feng XP ZP, Li JL, Yi H, et al. Comparative analysis of serum proteomes for discovery of biomarkers for human lung squamous carcinoma. Chin J Biochem Mol Biol. 2005;3:357-68.
17. Skonier J, Neubauer M, Madisen L, Bennett K, Plowman GD, Purchio AF. cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta. DNA Cell Biol. 1992;11(7):511-22.
18. Williams AF, Barclay AN. The immunoglobulin superfamily-domains for cell surface recognition. Ann Rev Immunol. 1988;6(1):381-405.
19. Wiesmann C, Katschke KJ, Yin J, Helmy KY, Steffek M, Fairbrother WJ, et al. Structure of C3b in complex with CRIg gives insights into regulation of complement activation. Nature. 2006;444(7116):217-20.
20. Schroeder J-M, Hansmann B, Wu Z. C-terminal ifapsoriasin fragments as antimicrobial peptides, the production thereof and use thereof. Google Patents; 2008.
21. Wu Z. Analysis of two human gene clusters involved in innate immunity: dissertation; 2005.
22. Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, et al. The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004;14(10B):2121-7. doi: 10.1101/gr.2596504.
23. Clark HF, Gurney AL, Abaya E, Baker K, Baldwin D, Brush J, et al. The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res. 2003;13(10):2265-70. doi: 10.1101/gr.12930031293003.
24. Jindal HK, Chaney WG, Anderson CW, Davis RG, Vishwanatha JK. The protein-tyrosine kinase substrate, calpactin I heavy chain (p36), is part of the primer recognition protein complex that interacts with DNA polymerase alpha. J Biol Chem. 1991;266(8):5169-76.
25. Zhang Y, Wolf-Yadlin A, Ross PL, Pappin DJ, Rush J, Lauffenburger DA, et al. Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules. Mol Cell Proteomics. 2005;4(9):1240-50. doi: 10.1074/mcp.M500089-MCP200.
26. Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell. 2006;127(3):635-48. doi: 10.1016/j.cell.2006.09.026.
27. Chi A, Valencia JC, Hu ZZ, Watabe H, Yamaguchi H, Mangini NJ, et al. Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes. J Proteome Res. 2006;5(11):3135-44. doi: 10.1021/pr060363j.
28. Langnaese K, Colleaux L, Kloos DU, Fontes M, Wieacker P. Cloning of Z39Ig, a novel gene with immunoglobulin-like domains located on human chromosome X. Biochim Biophys Acta. 2000;1492(2-3):522-5. S0167-4781(00)00131-7 [pii].
29. Wu Z. The human intermediate filament-associated protein family. Submitted (NOV-2004) to the EMBL/GenBank/DDBJ databases.
30. Procaccio V, Salazar G, Ono S, Styers ML, Gearing M, Davila A, et al. A mutation of beta -actin that alters depolymerization dynamics is associated with autosomal dominant developmental malformations, deafness, and dystonia. Am J Hum Genet. 2006;78(6):947-60. doi: 10.1086/504271.